Veterinary Medicines

Hypophysin LA 35 µg/ml solution for injection for cattle and pigs

Authorised
  • Carbetocin
Download as PDF

Product identification

Medicine name:
Hypophysin LA 35 µg/ml solution for injection for cattle and pigs
Depotocin 35 µg/ml Injektionslösung für Rinder und Schweine
Active substance:
  • Carbetocin
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Carbetocin
    35.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01BB03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID5) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s)
  • (ID4) 600 millilitre(s): unspecified outer container with 12 Vial (Glass) each with 50 millilitre(s)
  • (ID3) 50 millilitre(s): unspecified outer container with 1 Vial (Glass) with 50 millilitre(s)
  • (ID2) 20 millilitre(s): unspecified outer container with 1 Vial (Glass) with 20 millilitre(s)
  • (ID1) 10 millilitre(s): unspecified outer container with 1 Vial (Glass) with 10 millilitre(s)
  • (ID6) 1200 millilitre(s): unspecified outer container with 12 Vial (Glass) each with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Veyx Pharma GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401958.00.00
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0156/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (RTF)
Published on: 18/03/2024
Download

Package Leaflet

English (RTF)
Published on: 18/03/2024
Download

2401958-paren-20140521.pdf

English (PDF)
Published on: 18/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."